PHKG2 and non-small cell lung carcinoma: Furthermore, our study reveals that targeting NRF2 upregulates PHKG2, promoting ferroptosis, enhancing radiotherapy-induced mitochondrial stress-dependent iron toxicity, and increasing the sensitivity of NSCLC to radiotherapy.